Prospective, double-blind, randomized trial of teicoplanin versus vancomycin for the therapy of vascular access-associated bacteremia caused by gram-positive pathogens
- 1 January 1999
- journal article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 5 (4) , 208-212
- https://doi.org/10.1007/s101560050037
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Staphylococcus epidermidis: Emerging Resistance and Need for Alternative AgentsClinical Infectious Diseases, 1998
- The comparative efficacy and safety of teicoplanin and vancomycinJournal of Antimicrobial Chemotherapy, 1996
- Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman cathetersAntimicrobial Agents and Chemotherapy, 1989
- A sensitive bioassay for teicoplanin in serum in the presence or absence of other antibioticsDiagnostic Microbiology and Infectious Disease, 1989
- Teicoplanin revisitedJournal of Antimicrobial Chemotherapy, 1988
- Teicoplanin: A New Glycopeptide Antibiotic ComplexDrug Intelligence & Clinical Pharmacy, 1988
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987
- The "Red Man's Syndrome" and Slow Infusion of VancomycinAnnals of Internal Medicine, 1986
- Clinical Pharmacokinetics of VancomycinClinical Pharmacokinetics, 1986
- In vitro activity of teichomycin compared with those of other antibioticsAntimicrobial Agents and Chemotherapy, 1983